Sirius Investors
0.78
1.76%Today
NMTCNeuroOne Medical Technologies Corporation • NASDAQ Capital Market • Healthcare
Market Cap
39.17M
Volume
47.16K
52W High
1.39
52W Low
0.40

Company Overview

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Company Information

CEO
David A. Rosa
Sector
Healthcare
Industry
Medical - Devices
Employees
17

Contact Information

Address
7599 Anagram Drive
Country
US

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 39.17M market capitalization
  • Trading Volume: 47.16K shares traded today
  • Price Range: 52-week range of $0.40 - $1.39
  • Exchange: Listed on NASDAQ Capital Market

Financial Metrics

P/E Ratio:-4.90
EPS:$-0.16
Beta:0.68
Avg Volume:237.06K

Market Analysis for NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation (NMTC) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 39.17M, the company represents a significant player in its market. The stock is currently trading at $0.78 with a positivedaily change of 1.76%.

The company's 17 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -4.90, beta of 0.68, and 52-week price range from $0.40 to $1.39when evaluating investment opportunities.

Why Invest in NeuroOne Medical Technologies Corporation?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Capital Market)
  • • Experienced leadership under David A. Rosa
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.